EPH63 Exploring the Potential Public Health Benefits of a Respiratory Syncytial Virus (RSV) Vaccine Candidate (Ad26.RSV.preF/RSV) Among Individuals Aged 65 Years and Older in the UK: A Preliminary Mathematical Modelling Approach
Abstract
Authors
T Shiri A Cox A Lied Lied A Puggina R Chapman P Lozowicki C Duan L Hernandez-Pastor T Van Effelterre MJ Postma